Phyllis Barkman Ferrell

Phyllis Barkman Ferrell

March 7, 2014 -- usalzheimeradmin
Global Brand Development and Product Team Leader
Alzheimer’s Disease, Eli Lilly and Company
Indianapolis, IN

Phyllis Ferrell is currently the Global Brand Development and Product Team Leader for Alzheimer’s Disease in Lilly BioMedicines.  Phyllis and her team are responsible for the late-stage development and global registration of Solanezumab and subsequent launch and commercialization.  The team is also responsible for several other earlier stage assets targeted at treating patients and their caregivers that are battling Alzheimer’s.